A Phase I Pharmacokinetic and Biological Correlative Study of Oblimersen Sodium (Genasense, G3139), an Antisense Oligonucleotide to the Bcl-2 mRNA, and of Docetaxel in Patients with Hormone-Refractory…

Overview of attention for article published in Clinical Cancer Research, August 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

patent: 13 patents

Readers on

mendeley: 23 Mendeley

You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Article details
Title	A Phase I Pharmacokinetic and Biological Correlative Study of Oblimersen Sodium (Genasense, G3139), an Antisense Oligonucleotide to the Bcl-2 mRNA, and of Docetaxel in Patients with Hormone-Refractory Prostate Cancer
Published in	Clinical Cancer Research, August 2004
DOI	10.1158/1078-0432.ccr-03-0701
Pubmed ID	15297406
Authors	Anthony W. Tolcher, John Kuhn, Garry Schwartz, Amita Patnaik, Lisa A. Hammond, Ian Thompson, Howard Fingert, David Bushnell, Shazli Malik, Jeffrey Kreisberg, Elzbieta Izbicka, Leslie Smetzer, Eric K. Rowinsky

View on publisher site Alert me about new mentions

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline

Activity

Mendeley demographics

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country	Count	As %
China	1	4%
Unknown	22	96%

Demographic breakdown

Readers by professional status
Readers by professional status	Count	As %
Student > Master	4	17%
Student > Postgraduate	4	17%
Other	3	13%
Student > Bachelor	3	13%
Student > Ph. D. Student	3	13%
Other	5	22%
Unknown	1	4%

Readers by discipline
Readers by discipline	Count	As %
Medicine and Dentistry	7	30%
Agricultural and Biological Sciences	4	17%
Pharmacology, Toxicology and Pharmaceutical Science	2	9%
Biochemistry, Genetics and Molecular Biology	2	9%
Linguistics	1	4%
Other	3	13%
Unknown	4	17%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2021.

All research outputs

#4,764,468

of 23,051,185 outputs

Outputs from Clinical Cancer Research

#4,339

of 12,656 outputs

Outputs of similar age

#9,579

of 54,191 outputs

Outputs of similar age from Clinical Cancer Research

#25

of 134 outputs

Altmetric has tracked 23,051,185 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 12,656 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has gotten more attention than average, scoring higher than 58% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 54,191 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.

We're also able to compare this research output to 134 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.